NCT04523792View on ClinicalTrials.gov

Virginia Opioid Treatment-Emergency Department

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Opioid Use Disorder
Interventions
DRUG

SUBLOCADE

SUBLOCADE (buprenorphine extended-release) injection is a colorless to amber sterile solution for SC injection designed to deliver buprenorphine at doses of 100 mg or 300 mg at a controlled rate over a one-month period.

Sponsors

Collaborators (1)

Indivior, PLC.
All Listed Sponsors
collaborator

Indivior, PLC.

UNKNOWN

lead

Virginia Commonwealth University

OTHER

NCT04523792 - Virginia Opioid Treatment-Emergency Department | Biotech Hunter | Biotech Hunter